Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Find out when to change your budget based on your spending habits. Regular adjustments can improve your financial health.
23,632 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
As ATS gears up for its Q4 2026 results, investors want clarity on revenue momentum, margins, and guidance. This arti...
A new institutional stake in Howard Hughes Holdings suggests rising confidence in the stock. With 140,268 shares boug...
A strategic BTC sale and easing ETF inflows pushed Bitcoin to a two-month low. This article breaks down what happened...
A reserves-and-resources update put Coeur Mining back in focus, with millions of ounces of gold on the books and a pr...
Bitcoin retraced after a volatile stretch, pushing traders to rethink income-focused strategies. This piece breaks do...
Barings BDC (BBDC) fans the flames of income investing with a steady cash-flow model. As barings (bbdc) 2025 earnings...
A couple’s big casino win two years ago triggered higher Medicare premiums today, underscoring how IRMAA rules can su...
Cava's yearly revenue just crossed the $1 billion mark, signaling a major milestone for the fast-casual chain. This a...
When MoonLake Immunotherapeutics announced a larger-than-expected secondary offering, the stock wilted. This guide br...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
Europe’s move toward UN-led tax dialogue signals a broader shift in global rules. This article breaks down what that ...